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Identification and independent regulation of human mesangial cell
matrix metalloproteinases. Mesangial cells are known to secrete metallo-
proteinases that are capable of degrading the constituents of the GBM,
and hence are potentially involved not only in the regular maintenance of
the ECM components in the glomerulus, but also of contributing to any
damage to these components that occurs in disease states. In this report
we positively identify by Northern blotting the neutral proteinase that is
constitutively secreted by the human mesangial cell (HMC) as gelatinase
A (MMP2). Stimulation of HMC gelatinase by IL-1f3 or PMA causes an
increase in the total amount of gelatinolytic activity secreted. On exami-
nation, however, this increased activity is shown, both by immunoreactivity
and by PCR to be due to the induction of the higher molecular weight
form of gelatinase, gelatinase B (MMP9), while the amount of gelatinase
A remained unaffected. In addition antigen and messenger RNA have
been identified for both the specific inhibitors of metalloproteinases
TIMP-1 and TIMP-2. The appearance of the larger inducible gelatinase
with similar substrate specificity implies that the regular turnover of matrix
components may be due to the constitutively released gelatinase A while
in pathological situations the inducible gelatinase B becomes predomi-
nant. The synthesis and secretion of TIMP-1 and TIMP-2 indicates that
the mesangial cell is capable of controlling the activity of its own secreted
enzymes,
The turnover of the glomerular mesangial matrix is dependent
on a balance between its synthesis and degradation, and a change
in either of these dynamic parameters will potentially result in
morphological and functional changes within the glomerulus. The
breakdown of the matrix likely depends on the synthesis and
secretion of a variety of proteinases and of these the best
candidates are the matrix metalloproteins (MMP) that are active
in the extracellular milieu.
Previous studies in our laboratory using rat mesangial cells
demonstrated the release of a neutral protease with the potential
to degrade type IV collagen, the major component of glomerular
basement membrane [1]. Co-culture with rat macrophages could
enhance this secretion [2]. This finding was taken as evidence that
the control of glomerular matrix and basement membrane turn-
over was effected by endogenous glomerular cells and could be
influenced by cytokines or growth factors derived from infiltrating
cells during inflammation. The mesangial cell-derived neutral
protease was subsequently purified to homogeneity and was
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shown to be a protein doublet of 66 and 68 kD. It was dependent
on divalent cations for function and capable of degrading the
major constituent of GBM-type IV collagen with the release of
hydroxyproline [1]. These properties indicated that the neutral
protease belonged to the collagenase super gene family of metal-
loproteinases.
There are three main subgroups of this family of enzymes [3]:
the interstitial collagenases, stromelysins and type IV collagenases
(or gelatinases). Two distinct collagenases have been identified
which specifically cleave the triple helix of collagens type I, II, III
and X [4] as well as acting as serpinases by degrading serum
protease inhibitors [5]. Stromelysins, of which three have been
described have a broader substrate specificity and degrade pro-
teoglycans, laminin and types IV and V collagen in their non
helical regions. Finally, two type IV collagenases have been
identified, a large 92 kD enzyme (gelatinase B) [6] produced
mainly by neutrophils and macrophages and a 72 kD form
(gelatinase A) [7] produced mainly by connective tissue cells. Recent
studies have confirmed that the rat mesangial cell metalloprotein-
ases is related to gelatinase A [8].
The expression of MMP is regulated by a wide variety of
compounds including inflammatory cytokines such as IL-i [9],
growth factors such as TGF-J3 [lOj as well as the tumor promoting
agent PMA [11]. PMA and IL-i act through the same gene
promoter sequence (APi) to induce transcription and as such
have the potential to up-regulate synthesis of collagenase, strome-
lysin 1 and gelatinase B, all of which possess the APi sequence at
the 5' end of the gene [6, 12, 13]. In contrast the gene for the 72
kD gelatinase possesses an AP2 promoter site and appears to be
responsive to TGF-/3. This feature may allow independent regu-
lation of the two gelatinases.
A second level of control of MMP activity is achieved through
the secretion of specific inhibitors (TIMPs) of which two have
been described [14, 15]. TIMP-1 has a predeliction for the latent
92 kD enzyme and TIMP-2 for the smaller gelatinase A [16].
These inhibitors are also highly regulated by cytokines and growth
factors. Thus, the net amount of matrix layed down in tissue
depends on the relative concentration of active enzyme and
natural inhibitor.
In the present study we have sought to identify and characterize
the gelatinolytic enzymes of the human mesangial cell as well as
the synthesis of their inhibitors. In addition we confirm that their
regulation is along the lines of that previously described for other
human tissue cells.
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Fig. 1. Identity of the human mesangial cell
neutral proteinase. (A) Conditioned medium
from non-stimulated human mesangial cell
cultures was run on a 7.5% acrylamide gel
containing gelatin (1 mg/mI) under non-
reducing conditions. The presence of
gelatinolytic activity is demonstrated by the
zones of lysis in Coomasie blue stained gels. (B)
Northern blot of human mesangial cell RNA
probed with cDNA fragment identical to the
published sequence for the 72 kD gelatinase.
Ribosomal RNA markers are shown. (C) PCR
of HMC cDNA using primers derived from the
published sequence for the 72 kD gelatinase.
(D) Ribonuclease protection assay of HMC
RNA using a probe reverse transcribed from
the cDNA to the published sequence of
gelatinase A, showing a single protected
fragment. Positive control, negative control and
10 g of total HMC RNA are shown.
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Methods
Materials
Tris, CaCl2, Brij, acrylamide and lactalbumin hydrolysate (LH)
were purchased from Imperial Laboratories (Europe) Ltd; Coo-
masie Blue from BioRad Laboratories Ltd and reverse tran-
scriptase (AMy), Taq polymerase, agarose and restriction endo-
nucleases from Northumbria Biologicals Ltd; nylon membranes
(Hybond) and 32P-dCTP from Amersham International plc; RNa-
zol B from Biogenesis Ltd; RNasin from Promega Ltd. Phorbol
myristate acetate (PMA) and p-aminophenylmercuric acetate
(PAMA) were purchased from Sigma Chemical Co. (Poole, UK).
Antibodies to TIMP-1 and the appropriate pure standard were
gifts of Dr. P. Davies (Merck, Rahway, New Jersey, USA) and
anti-92 kD gelatinase was provided by Gill Murphy (Strangeways
Laboratoiy, Cambridge, UK). The eDNA probe to the 72 kD
gelatinase was provided by Celitech Ltd, Slough, as was the
anti-TIMP-2 antibody together with standards.
Primers based on the published sequences of neutral protein-
ases and their inhibitors [14, 15, 17, 18] were obtained from either
Oswell DNA Service (Edinburgh, UK) or synthesized at the
UWCM, Cardiff.
The following sequences were used:
Establishment of mesangial cells in culture
Human glomerular cell cultures were initiated from specimens
of normal kidney obtained at nephrectomy. The glomeruli were
isolated from the renal cortex by serial sieving as previously
described [19] and collected on a 125 sm sieve. Following
treatment with bacterial collagenase (750 U/mI; Sigma) for 30
minutes the glomerular cores were washed X3 with PBS and
plated out in RPMI 1640 buffered by NaHCO3 and supplemented
with 20% FCS, glutamine, 5 g/ml insulin and 5 sWml transferrin.
Mesangial cell outgrowths usually appear after approximately one
week in culture. Non-adherent glomeruli were removed by thor-
ough washing, and the adherent cells were further cultured in the
above medium. When confluent the mesangial cells were passaged
using tiypsin-EDTA up to 10 times. The cells were characterized
by morphology and by the use of specific antibodies. They showed
+ve staining for intracellular myosin fibrils, were —ye for factor
VIII, and non-specific esterase activity was not detected. Four
separate mesangial cell lines were used in these experiments.
Enzymatic assays
Gelatinase activity was assayed in vitro by the degradation of
'4C labeled gelatin. This was obtained from heat denatured (60°C,
30 mm) rat tail tendon collagen prepared as described by Cawston
and Barrett [20]. For the production of conditioned medium,
mesangial cells were washed three times with sterile PBS to
remove all traces of FCS and the culture continued with serum
free medium supplemented with lactalbumin hydrolysate at a final
concentration of 0.2% (wt/vol). The cells were rested in this
medium for 48 hours before stimulation with the appropriate
PMA (10 flM) LH
Fig. 2. Induction of HMC total gelatinase activity by IL-I and PMA. Rested
human mesangial cell cultures were stimulated with (A) IL-i (1-10 ng/ml)
or (B) PMA (10 nM) in serum free conditions for 72 hours, and the
conditioned medium was assayed for total gelatinase activity. Control cells
were cultured in serum free medium (LH). Data are from separate
representative experiments performed in triplicate.
cytokine. The culture was continued for a further three days, after
which the medium was collected, centrifuged to remove any debris
present and stored at —20°C until assayed for enzymatic activity as
previously described [1]. The number of cells per well was not
altered in the experimental versus control wells at the end of the
culture period (mean 3.03 0.723 X iO well). Samples contain-
ing gelatinase activity were also run on standard non-reducing
SDS polyacrylamide gels containing gelatin at a final concentra-
tion of 1 mg/mI at 4°C. The gels were then washed in 50 mM
Tris HCI pH 7.6 containing 10 mivi CaC12 and 0.05% Brij and
incubated in the same buffer at 37°C overnight. The presence of
gelatinase activity was demonstrated by zones of lysis in the
Coomasie Blue stained gel.
Northern blotting
Total RNA was extracted from confluent flasks by the use of
RNazol B following the manufacturer's recommended protocol.
The RNA (up to 50 jsg) was run on 1% agarose gels incorporating
formaldehyde, transferred to nylon membranes, immobilized by
exposure to UV for three minutes and probed with the sequence
of interest.
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Fig. 3. Characterization of
induced gelatinase activity.
Human mesangial cell cultures
were stimulated with (A) IL-i
(0 to 10 nglml) and (B) PMA
(10 nM) for 72 hours. The
conditioned medium was
electrophoresed on a 7.5%
gelatin gel. Two distinct bands
of enzyme activity are visible
in the stimulated samples; at
68 kD and 92 kD. A. A dose
dependent increase in
gelatinolytic activity at 92 kD
following IL-i stimulation. B.
The induction of the 92 kD
enzyme following the addition
of 10 flM PMA.
Reverse transcription polymerase chain reaction (RT PCR)
For reverse transcription followed by PCR, total HMC RNA
(1 g) was denatured at 95°C for 10 minutes followed by reverse
transcription using 10 U AMV in the presence of 1 U/mI RNasin
and 1 m of dNTPs, together with 20 pmol random hexamers
(Promega). After annealing at room temperature for 10 minutes,
the cDNA was produced by reverse transcription for one hour at
42°C using the Taq polymerase buffer. A sample (equivalent to
0.15 jg RNA) of the cDNA obtained was then taken, diluted to
a final 25 j.d with lx Taq buffer, together with specific primers (20
pmol) and 2 units of Taq polymerase were added. The sample was
overlaid with mineral oil and the polymerase chain reaction was
then carried out in a Perkin Elmer/Cetus thermal cycler. The PCR
reactions were performed as follows. The samples were heated
over 30 seconds to 95°C, and denatured for a further 30 seconds,
cooled over 30 seconds to 52°C and annealed at this temperature
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Fig. 4. Identification of the high molecular weight gelatinase. HMC CM
containing the high molecular weight gelatinase was incubated with
antibody specific to gelatinase B and precipitated with protein A. (Lane A)
92 kD gelatinase standard. (Lane B) IL-i (10 ng,Iml) stimulated CM
before immunoprecipitation. (Lane C) a single band of gelatinolytic
activity was immunoprecipitated by anti-92 kD antibody.
for one minute, then heated over 30 seconds to 72°C and
incubated at 72°C for one minute. The cycle was repeated 35
times.
Radionuclease protection assay
The ribonuclease protection assay was carried out with the use
of RPA II assay kit supplied by AMS Biotechnology (UK) Ltd
following the manufacturer's instructions. The RNA probe was
transcribed from the plasmid containing cDNA for the 72 kDa
gelatinase described above.
Results
Constitutive generation of gelatinolytic activity
Human mesangial cells at passage 4-10 were cultured in lactal-
bumin and examined for the release of gelatin degrading protein-
ases. Supernatant from these resting cells was electrophoresed on
SDS-PAGE gelatin substrate gel under non-reducing conditions.
A major zone of gelatinolytic activity was observed at 68 kD, but
a smaller band of activity was also seen occasionally at 92 kD (Fig.
1A). The same supernatant was applied to a casein substrate gel
but no zones of lytic activity were seen (data not shown).
Total RNA from mesangial cells of the same passage number
was isolated, electrophoresed and transferred to a nylon mem-
brane. This was probed with a specific cDNA probe to the
published sequence for gelatinase A. Following washing under
Fig. 5. Identification of mRNA for 92 kD gelatinase. PCR or HMC cDNA
from resting mesangial cells (Lane A) and PMA (10 nM) stimulated cells
(Lane B), utilising RNA extracted 12 hours following stimulation using 92
kD gelatinase specific primers. A single band of 1100 base pairs corre-
sponding to that predicted by the gelatinase B sequence was generated.
stringent conditions (0.1% SDS, 0.1 X SSC, 65°C) for one hour, a
transcript of 3.1 kb was detected (Fig. 1B), a size appropriate to
the 72 kD gelatinase.
In addition, using primers designed from the published se-
quence of the 72 kD gelatinase a single band of 620 base pairs was
obtained following RT-PCR as predicted by the primers selected
(Fig. 1C) confirming that the mesangial 72 kD gelatinase was
identical to that identified and cloned from H-ras transformed
bronchial epithelial cells.
Finally, a ribonuclease protection assay (RPA) using 10 g of
total HMC RNA showed that an RNA probe prepared from the
cDNA used above protected a single band of message (Fig. 1D).
Induced generation of gelatinolytic activity
Resting cultured human mesangial cells generated small
amounts of gelatinolytic activity as measured by the [3H]-gelatin
assay. The addition of IL-i (1 to 10 ng/ml) or PMA (10 nM)
resulted in an increase in gelatin degrading activity (Fig. 2 A, B).
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Fig. 6. Expression of TIMP-1 and T!MP-2. Western blots of HMC CM showing (A) a single band of 28 kD is seen when the blot is probed with
anti-TIMP-1 antibody, (B) a single band of 21 kD is seen when the blot is probed with TIMP-2 specific antibody.
This increase was significant at a concentration of IL-i of 10 ng/mI
(P = 0.0337, N = 4). PMA was shown to cause a significant
increase at a concentration of 10 flM (P = 0.0176, N = 6). A typical
experiment is shown. Degradation was measured in the presence
of PAMA (1 mM) which allowed total enzyme activity to be
assessed.
Analysis of the induced gelatinolytic activity
Equal volumes of supernatants from mesangial cell cultures
containing 30,3 X iO mesangial cells exposed to increasing doses
of IL-i (range 0.1 to 10 ng/ml) were electrophoresed on an
SDS-PAGE gelatin gel under non-reducing conditions. After
staining there was a clear dose dependent increase in the zones of
lysis corresponding to an enzyme of molecular weight 92 kD. In
contrast there was a slight decrease in the band of lysis at 72 kD
(Fig. 3A). No changes in cell number or ATP concentration
were seen in the experimental compared to control wells (3.03
0.723 X i05 cells per well, N = 24). It is of interest that the level
of gelatinase A appears to decrease with increasing IL-i concen-
tration, demonstrating that the increase in gelatinase B can not be
due to an increase in cell number. An increase in the activity of 92
kD enzyme was seen after PMA stimulation with concentrations
of PMA above 108 M (Fig. 3B).
Characterization of the high molecular weight enzyme
The identity of the higher molecular weight band was achieved
by a two step approach.
(i). Supernatants from human mesangial cell cultures stimu-
lated with IL-i (10 ng/ml) were incubated for 30 minutes with a
specific antibody to the 92 kD gelatinase. The antigen antibody
complex was precipitated with protein A-Sepharose and subjected
to SDS-PAGE electrophoresis under non-reducing conditions. A
single band of protein was seen of the appropriate molecular
weight (Fig. 4).
(ii). RNA was extracted from resting mesangial cells and from
cells after stimulation with PMA (10 M for 12 hr) and reverse
transcribed using random primers. cDNA (equivalent to 0.15 g
RNA) was amplified by PCR using specifically designed primers
to gelatinase B. There was a single band of amplified DNA
generated from the RNA of the stimulated cells but not from the
RNA of resting cells (Fig. 5). This band corresponded to that
expected for the 92 kD transcript (1100 base pairs) and was
cleaved with Barn Hi, confirming its identity. Interestingly, there
was no change in the message for the 72 kD enzyme in these
experiments. These results confirmed that the human mesangial
cells were capable of synthesizing not only the 72 kD gelatinase
but also the one of higher molecular weight which is usually a
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Fig. 7. Message for TIMP-1 and TIMP-2. PCR
of HMC cDNA using primers specific for (A)
TIMP-1 and (B) TIMP-2.
product of inflammatory cells, and that the message for this
gelatinase is induced within 12 hours of stimulation by PMA.
Generation of specific inhibitors
Supernatants from resting mesangial cells were also examined
for the generation of specific metalloproteinase inhibitors. SDS-
PAGE electrophoresis of these supernatants were transblotted
onto nitrocellulose membranes and incubated with monospecific
antibodies to either TIMP-1 or TIMP-2. In both cases lines of
precipitation were seen at the appropriate molecular weight for
each inhibitor (Fig. 6).
RNA extracted from mesangial cells was reversed transcribed
and the resulting cDNA amplified by PCR using primers designed
from the published sequences of either TIMP-1 or TIMP-2. In
both cases single bands were obtained of the appropriate size for
the section of message being amplified for each inhibitor
(TIMP-1, 520 base pair fragment; TIMP-2, 540 base pair frag-
ment; Fig. 7).
Discussion
The present study demonstrates that human mesangial cells in
culture synthesize and release two distinct neutral metalloprotein-
ase enzymes as well as two specific enzyme inhibitors. The 68 to 72
kD gelatinase previously purified from mesangial cells [19, 21, 22]
is clearly very similar to that isolated and sequenced from
transformed epithelial cells [181. In the present study the similar-
ity is further complemented (1) by Northern blot analysis of RNA
from human mesangial cells using a probe to the gelatinase A
generated from the published cDNA sequence [18], (2) by a
positive PCR of the expected size using primers derived from this
same sequence, and (3) by a positive ribonuclease protection assay
using an RNA probe transcribed from the plasmid containing
eDNA of gelatinase A. This enzyme (gelatinase A) degrades not
only GBM releasing hydroxyproline fragments but also proteogly-
cans which are important constituents of the extracellular matrix
[19, 21]. In addition, studies of renal biopsies have shown this
enzyme to be present in small amounts in the normal glomerulus,
indicating a role in the non-pathological turnover of the mesangial
glomerular matrix.
Our studies also identified a higher molecular weight enzyme of
92 kD which had gelatinolytic activity. Occasionally a small
amount of the enzyme was present in the supernatant derived
from "resting cells" but in general it appeared only after cytokine
or PMA induction. This enzyme was also subjected to further
analysis at the protein and molecular level and was identical to
that normally found in inflammatory cells and labeled as gelati-
nase B [6]. In addition to these (two) enzymes, human mesangial
cells also generate and secrete two distinct tissue inhibitors. The
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presence of TIMP-2 in addition to the previously described
TIMP-1 [19] as a product of the mesangial cell is important since
TIMP-2 binds to the latent 72 kD gelatinase [23j and therefore
may seem to control the role of this enzyme under non-patholog-
ical conditions. TIMP-1 by contrast binds to the latent 92 kD
gelatinase and prevents both dimerization as well as activation of
the enzyme with stromelysin [24].
We have previous demonstrated that rat mesangial cells gener-
ate increased gelatinolytic activity when stimulated with IL-i. The
present study indicates that human cells respond likewise to IL-i
as well as to PMA. Our original studies also implied that the
response of the rat cells was by up-regulation of the 72 kD
enzymes and this is supported by a recent report [8] that IL-i does
indeed induce secretion of the 72 kD enzyme by rat mesangial
cells.
Studies in human cells, however [25, 26], demonstrate that the
gene encoding the 72 kD enzyme does not have an IL-i response
element (APi) in its promoter sequence. This gene in fact
possesses an AP2 promoter site. In addition it appears to be
induced by TGF-f3 [10, 27—29]. In contrast, the gene encoding the
92 kD enzyme (gelatinase B) does possess an APi site or TRE
[TPA (PMA) responsive element] in its promoter region and
would therefore be expected to respond to both IL-i as well as to
PMA. Thus the present study is in agreement with studies in the
human fibroblast where only the production of gelatinase B is
increased following the addition of IL-i [30]. Furthermore, it
contrasts with the response of the rat mesangial cell where IL-i
apparently induces secretion of gelatinase A (72 kD enzyme) and
indicates that there may be different regulation of metalloprotein-
ase production in rat and human cells. Alternatively this apparent
difference in control may be linked to the potential hazards of
tissue culture. Changes have been observed in the secretion of
metalloproteinases by rat cell lines with increasing passage num-
ber.
Thus, it seems both from this and others studies that the 72 kD
enzyme is produced under steady state conditions. This would
imply that this enzyme may be linked to the normal turnover of
the extracellular matrix. Under pathological conditions with the
influx of inflammatory cells into the glomerulus, the secretion of
cytokines may result in the induction of the 92 kD enzyme which
has a similar substrate specificity. The difference between the two
enzymes, however, lies in their propensity to activation. They
appear to be activated by different mechanisms. It has been
reported [31] that the gelatinase A cannot be activated by serine
proteinases such as plasmin and trypsin, nor by activated strome-
lysin (MMP3)—compounds which are claimed to activate other
members of the metalloproteinase family. A report by Wong,
Cortez and Baricos [32], however, suggests that mesangial cell
derived gelatinase A can be activated by plasmin (although this is
possibly by an indirect mechanism). More recent studies by Okada
et al [33] show that pure (TIMP free) gelatinase B can be
activated by trypsin and MMP3, but not by plasmin. So although
there are conflicting reports on the propensity of these two forms
of gelatinase to be activated by endogenous proteinases, they do
appear to be subject to different mechanisms of activation. In
addition, the fact that each gelatinase complexes specifically with
a particular inhibitor will also be significant in deciding which
enzyme is of greatest biological significance, given that the
inhibitors also appear to be separately regulated [34].
Reprint requests to Dr. John D. Williams, University of Wales College of
Medicine, Institute of Nephrology, Cardiff Royal Infirmaty, Newport Road,
Cardiff CF2 1SZ Wales, United Kingdom.
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